Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders in Children and Adolescent/Young Adult Patients
Conditions
Interventions
TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplant (HSCT)
Locations
1
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Start Date
September 16, 2019
Primary Completion Date
May 14, 2021
Completion Date
September 3, 2021
Last Updated
September 8, 2023
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions